![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Announces Corporate Reorganization to Focus on Development Objectives
18 nov. 2011 11h45 HE
|
Myrexis, Inc.
Internal Resources Realigned to Support Development Strategy
Further 20% Reduction in Workforce and $1.8 Million in Annual Cost Reduction
SALT LAKE CITY, Nov. 18, 2011 (GLOBE NEWSWIRE) --...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Presents at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
14 nov. 2011 09h05 HE
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Reports First Quarter Fiscal Year 2012 Results
09 nov. 2011 16h11 HE
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
CORRECTION -- Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
03 nov. 2011 18h03 HE
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- In a press release issued earlier today by Myrexis, Inc. (Nasdaq:MYRX) with the same headline, please note that the conference call will be held on...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis to Present at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
03 nov. 2011 16h02 HE
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
03 nov. 2011 16h02 HE
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Appoints Jason M. Aryeh to its Board of Directors
20 oct. 2011 16h37 HE
|
Myrexis, Inc.
SALT LAKE CITY, Oct. 20, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis to Participate in the 2011 UBS Global Life Sciences Conference
14 sept. 2011 16h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis to Present at 2011 Rodman and Renshaw Healthcare Conference
09 sept. 2011 09h29 HE
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Reports Fourth Quarter and Fiscal Year 2011 Results
08 sept. 2011 16h02 HE
|
Myrexis, Inc.
Clinical Development Strategy Update
Conference Call Today at 4:30 pm EDT
SALT LAKE CITY, Sept. 8, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the...